Published • loading... • Updated
The View of Raiffeisen Chief Economists: Pharma Wake-up Call
Summary by Moneycab
1 Articles
1 Articles
Customs duties are not an unproblematic instrument for driving the pharmaceutical industry to a halt, but they impose a burden on the pharmaceutical industry, but they also increase drug prices and thus increase the costs for end-users.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium